BioCentury | Oct 11, 2010
Company News

Brain Factory, Eisai deal

...Eisai granted Brain Factory exclusive rights to develop and commercialize E1224 in Japan to treat fungal infections...
...rights to develop and commercialize E1224 in Japan to treat fungal infections, excluding Chagas disease. Brain Factory...
...to develop E1224 for Chagas disease under a 2009 deal (see BioCentury, Oct. 5, 2009). Brain Factory Co. Ltd....
Items per page:
1 - 1 of 1
BioCentury | Oct 11, 2010
Company News

Brain Factory, Eisai deal

...Eisai granted Brain Factory exclusive rights to develop and commercialize E1224 in Japan to treat fungal infections...
...rights to develop and commercialize E1224 in Japan to treat fungal infections, excluding Chagas disease. Brain Factory...
...to develop E1224 for Chagas disease under a 2009 deal (see BioCentury, Oct. 5, 2009). Brain Factory Co. Ltd....
Items per page:
1 - 1 of 1